93 drugmakers face damage suits

Published: 2010-01-20 07:00:00

Updated: 2010-01-20 07:00:00

The state-run National Health Insurance Corporation says it has filed six suits against a total of 93 pharmaceutical firms, for financial damage caused by data fabrication on bioequivalence testing.

“We have filed damages against 93 drug manufactures based on falsified bioequivalence testing,'...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK